Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

In search of the tumour-suppressor functions of BRCA1 and BRCA2.

Scully R, Livingston DM.

Nature. 2000 Nov 23;408(6811):429-32.

2.

Insights into the functions of BRCA1 and BRCA2.

Welcsh PL, Owens KN, King MC.

Trends Genet. 2000 Feb;16(2):69-74. Review.

PMID:
10652533
3.

Role of BRCA gene dysfunction in breast and ovarian cancer predisposition.

Scully R.

Breast Cancer Res. 2000;2(5):324-30. Epub 2000 Jul 13. Review.

4.

The pathology of familial breast cancer: How do the functions of BRCA1 and BRCA2 relate to breast tumour pathology?

Bertwistle D, Ashworth A.

Breast Cancer Res. 1999;1(1):41-7. Epub 1999 Oct 27. Review.

5.

Interactions between BRCA proteins and DNA structure.

Scully R.

Exp Cell Res. 2001 Mar 10;264(1):67-73. Review. No abstract available.

PMID:
11237524
6.

BRCA1 and BRCA2 in breast cancer.

Yang X, Lippman ME.

Breast Cancer Res Treat. 1999 Mar;54(1):1-10. Review.

PMID:
10369075
7.

BRCA1 and prostate cancer.

Rosen EM, Fan S, Goldberg ID.

Cancer Invest. 2001;19(4):396-412. Review.

PMID:
11405179
8.

Developmental studies of Brca1 and Brca2 knock-out mice.

Hakem R, de la Pompa JL, Mak TW.

J Mammary Gland Biol Neoplasia. 1998 Oct;3(4):431-45. Review.

PMID:
10819537
9.

DNA polymerase stalling, sister chromatid recombination and the BRCA genes.

Scully R, Puget N, Vlasakova K.

Oncogene. 2000 Dec 11;19(53):6176-83. Review.

10.

BRCA1 and BRCA2 proteins: roles in health and disease.

Duncan JA, Reeves JR, Cooke TG.

Mol Pathol. 1998 Oct;51(5):237-47. Review.

11.

Accumulation of p53 protein is frequent in ovarian cancers associated with BRCA1 and BRCA2 germline mutations.

Zweemer RP, Shaw PA, Verheijen RM, Ryan A, Berchuck A, Ponder BA, Risch H, McLaughlin JR, Narod SA, Menko FH, Kenemans P, Jacobs IJ.

J Clin Pathol. 1999 May;52(5):372-5.

12.

Lessons learned from BRCA1 and BRCA2.

Zheng L, Li S, Boyer TG, Lee WH.

Oncogene. 2000 Dec 11;19(53):6159-75. Review.

13.
14.

BRCA1 and BRCA2 are necessary for the transcription-coupled repair of the oxidative 8-oxoguanine lesion in human cells.

Le Page F, Randrianarison V, Marot D, Cabannes J, Perricaudet M, Feunteun J, Sarasin A.

Cancer Res. 2000 Oct 1;60(19):5548-52.

15.

Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families.

Tonin PN, Mes-Masson AM, Futreal PA, Morgan K, Mahon M, Foulkes WD, Cole DE, Provencher D, Ghadirian P, Narod SA.

Am J Hum Genet. 1998 Nov;63(5):1341-51.

16.

The BRCA1 and BRCA2 breast cancer genes.

Casey G.

Curr Opin Oncol. 1997 Jan;9(1):88-93. Review.

PMID:
9090499
17.

A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.

Machácková E, Foretová L, Navrátilová M, Valík D, Claes K, Messiaen L.

Cas Lek Cesk. 2000 Oct 11;139(20):635-7.

PMID:
11192759
18.

BRCA1 and BRCA2 and the genetics of breast and ovarian cancer.

Welcsh PL, King MC.

Hum Mol Genet. 2001 Apr;10(7):705-13. Review.

PMID:
11257103
19.

Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells.

Chen J, Silver DP, Walpita D, Cantor SB, Gazdar AF, Tomlinson G, Couch FJ, Weber BL, Ashley T, Livingston DM, Scully R.

Mol Cell. 1998 Sep;2(3):317-28.

20.

Increased frequency of TP53 mutations in BRCA1 and BRCA2 ovarian tumours.

Ramus SJ, Bobrow LG, Pharoah PD, Finnigan DS, Fishman A, Altaras M, Harrington PA, Gayther SA, Ponder BA, Friedman LS.

Genes Chromosomes Cancer. 1999 Jun;25(2):91-6.

PMID:
10337991

Supplemental Content

Support Center